EDWARD GREEN: Open Payments
NPI 1770015638 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,152 in 156 payments from 35 companies in 2025. Trend: 2023 $2,132 · 2024 $3,027 · 2025 $3,152
Food & beverage: $3,152
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 25 | $487 |
| AstraZeneca Pharmaceuticals LP | 16 | $360 |
| Bayer Healthcare Pharmaceuticals Inc. | 24 | $271 |
| Merck Sharp & Dohme LLC | 10 | $235 |
| GlaxoSmithKline, LLC. | 8 | $190 |
| Stemline Therapeutics Inc. | 6 | $147 |
| Gilead Sciences, Inc. | 6 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Daiichi Sankyo Inc. | 5 | $115 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
Products named: Nubeqa, KEYTRUDA, ENHERTU, OJJAARA, PADCEV, Orserdu, Trodelvy, IMFINZI.
Industry payments across FL — which companies pay providers there.
